Cargando…

Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up

BACKGROUND: Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from those who do not. 2-(18)fluoro-deoxy-D-glucose (FDG) positron emission tomography (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conduit, Ciara, Koh, Thuan Tzen, Hofman, Michael S, Toner, Guy C, Goad, Jeremy, Lawrentschuk, Nathan, Tai, Keen-Hun, Lewin, Jeremy H, Tran, Ben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548159/ https://www.ncbi.nlm.nih.gov/pubmed/36209121 http://dx.doi.org/10.1186/s40644-022-00496-w

Ejemplares similares

A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours
por: Conduit, Ciara, et al.
Publicado: (2022)

The role of (18)F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
por: Hung, Te-Jui, et al.
Publicado: (2019)

18F-FDG PET/CT with unusual bone and CNS metastases from testicular seminoma
por: Gómez, Francisco Javier García, et al.
Publicado: (2015)

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study
por: Conduit, Ciara, et al.
Publicado: (2022)

Spermatocytic Seminoma With Sarcoma: An Indication for Adjuvant Chemotherapy in Localized Disease
por: Wetherell, David, et al.
Publicado: (2013)

End-of-Treatment FDG PET-CT (EOT-PET) in Patients with Post-Chemotherapy Masses for Seminoma: Can We Avoid Further Intervention?
por: Joel, Anjana, et al.
Publicado: (2022)

Active surveillance: minimising treatment while maximising outcomes in testis cancer
por: Conduit, Ciara, et al.
Publicado: (2023)

Surveillance following orchidectomy for stage I testicular seminoma.
por: Horwich, A., et al.
Publicado: (1992)

An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
por: Thomas, R., et al.
Publicado: (1996)

How We Read Oncologic FDG PET/CT
por: Hofman, Michael S., et al.
Publicado: (2016)

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment
por: Quak, Elske, et al.
Publicado: (2015)

Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom
por: Toner, Liam, et al.
Publicado: (2016)

Thymic seminoma
por: Kannan, J., et al.
Publicado: (2009)

Ovarian Seminoma
Publicado: (1913)

Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma
por: Crozier, Jack, et al.
Publicado: (2017)

Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance
por: Chung, Peter, et al.
Publicado: (2015)

DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma
por: Brait, M, et al.
Publicado: (2012)

Chemotherapy of metastatic seminoma.
por: Schuette, J., et al.
Publicado: (1985)

Update on management of seminoma
por: Alexander, Emma J., et al.
Publicado: (2010)

Ovotesticular Disorder With Seminoma
por: Samantray, Subha R, et al.
Publicado: (2020)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

(18)F-FDG PET-CT for Surveillance of Brazilian Patients with Li-Fraumeni Syndrome
por: Nogueira, Sonia Tereza Santos, et al.
Publicado: (2015)

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer
por: Lee, Hwanhee, et al.
Publicado: (2023)

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism
por: Hofman, Michael S, et al.
Publicado: (2011)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Improving outcomes in germ cell cancers using miRNA
por: Conduit, Ciara, et al.
Publicado: (2021)

Parotid gland metastasis of lung adenocarcinoma identified on surveillance (18)F-FDG PET/CT
por: Soputro, Nicolas Adrianto, et al.
Publicado: (2022)

Targeted alpha-particle therapy in neuroendocrine neoplasms: A systematic review
por: Koh, Thuan Tzen, et al.
Publicado: (2021)

Seminoma in the Testis Presenting as Hemospermia
por: Beji, Sami, et al.
Publicado: (2012)

Personalised surveillance after treatment for high-risk cancer
por: Guo, Christina, et al.
Publicado: (2019)

FDG-PET in colorectal cancer
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

FDG-PET and colon cancer
por: Miles, Ken
Publicado: (2015)

Testicular seminoma – unusual histology and staging with sub epithelial spread of seminoma along the vas deferans
por: Lockett, Chris J, et al.
Publicado: (2006)

An Uncommon Presentation of a Metachronous Testicular Primary Nonseminoma and Seminoma Separated by Two Decades and a Testicular Cancer Literature Review
por: Buck, Dennis Andrew, et al.
Publicado: (2017)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
por: Joffe, Johnathan K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_60hmfad4qm5nuejh94gq2upras